Terms: = Germ cell tumor AND SOCS1, O15524, 8651, ENSG00000185338, SOCS-1, SSI-1, SSI1, Cish1, JAB, CISH1, CIS1, TIP3
55 results:
1. Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade.
Chen S; McMiller TL; Soni A; Succaria F; Sidhom JW; Cappelli LC; Casciola-Rosen LA; Morales IR; Sankaran P; Berger AE; Deutsch JS; Zhu QC; Anders RA; Hooper JE; Pardoll DM; Lipson EJ; Taube JM; Topalian SL
J Transl Med; 2024 Mar; 22(1):241. PubMed ID: 38443917
[TBL] [Abstract] [Full Text] [Related]
2. Synthetic High-Density Lipoprotein-Based Nanomedicine to Silence socs1 in tumor Microenvironment and Trigger Antitumor Immunity against Glioma.
Yang C; Li Y; Yang Y; Ni Q; Zhang Z; Chai Y; Li J
Angew Chem Int Ed Engl; 2023 Dec; 62(49):e202312603. PubMed ID: 37847126
[TBL] [Abstract] [Full Text] [Related]
3. The Effect of 5-aza,2'-deoxyCytidine (5 AZA CdR or Decitabine) on Extrinsic, Intrinsic, and JAK/STAT Pathways in Neuroblastoma and Glioblastoma cells Lines.
Sanaei M; Kavoosi F
Asian Pac J Cancer Prev; 2023 Jun; 24(6):1841-1854. PubMed ID: 37378911
[TBL] [Abstract] [Full Text] [Related]
4. Identification and validation of socs1/2/3/4 as potential prognostic biomarkers and correlate with immune infiltration in glioblastoma.
Dai L; Han Y; Yang Z; Zeng Y; Liang W; Shi Z; Tao Y; Liang X; Liu W; Zhou S; Xing Z; Hu W; Wang X
J Cell Mol Med; 2023 Aug; 27(15):2194-2214. PubMed ID: 37315184
[TBL] [Abstract] [Full Text] [Related]
5. [miR-155-5p alleviates lipopolysaccharide-induced inflammatory damage of human SH-SY5Y neuroblastoma cells by down-regulating socs1].
Zhou H; Zhou L; Zhang C; Zhou L; Han Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Mar; 39(3):220-229. PubMed ID: 36946346
[TBL] [Abstract] [Full Text] [Related]
6. Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors.
Aydin B; Beklen H; Arga KY; Bayrakli F; Turanli B
J Endocrinol Invest; 2023 Apr; 46(4):727-747. PubMed ID: 36306107
[TBL] [Abstract] [Full Text] [Related]
7. National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States.
Ostrom QT; Shoaf ML; Cioffi G; Waite K; Kruchko C; Wen PY; Brat DJ; Barnholtz-Sloan JS; Iorgulescu JB
Neuro Oncol; 2023 Apr; 25(4):799-807. PubMed ID: 35994777
[TBL] [Abstract] [Full Text] [Related]
8. [Newly diagnosed melanoma diagnosed on the basis of cutaneous side effects from COVID-19 vaccine].
Eskandarani HA; Gjørup C; Nørgaard P; Hölmich LR
Ugeskr Laeger; 2022 May; 184(22):. PubMed ID: 35656609
[TBL] [Abstract] [Full Text] [Related]
9. Applicability of contemporary quality indicators in vestibular surgery-do they accurately measure tumor inherent postoperative complications of vestibular schwannomas?
Schipmann S; Lohmann S; Al Barim B; Suero Molina E; Schwake M; Toksöz ÖA; Stummer W
Acta Neurochir (Wien); 2022 Feb; 164(2):359-372. PubMed ID: 34859305
[TBL] [Abstract] [Full Text] [Related]
10. Clavipyrrine A, a unique polycyclic nitrogenous meroterpenoid with promising anti-glioma effects isolated from the fungus Clitocybe clavipes.
Sun Z; Chen D; Li L; Hou Y; Chen M; Huang G; Ma G; Li Z
Bioorg Chem; 2021 Dec; 117():105468. PubMed ID: 34768204
[TBL] [Abstract] [Full Text] [Related]
11. p53 affects epigenetic signature on socs1 promoter in response to TLR4 inhibition.
Sheikh T; Sen E
Cytokine; 2021 Apr; 140():155418. PubMed ID: 33476981
[TBL] [Abstract] [Full Text] [Related]
12. Suppressor of cytokine signaling 1 inhibits the maturation of dendritic cells involving the nuclear factor kappa B signaling pathway in the glioma microenvironment.
He M; Chen X; Luo M; Ouyang L; Xie L; Huang Z; Liu A
Clin Exp Immunol; 2020 Oct; 202(1):47-59. PubMed ID: 32516488
[TBL] [Abstract] [Full Text] [Related]
13. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy.
Wei J; Long L; Zheng W; Dhungana Y; Lim SA; Guy C; Wang Y; Wang YD; Qian C; Xu B; Kc A; Saravia J; Huang H; Yu J; Doench JG; Geiger TL; Chi H
Nature; 2019 Dec; 576(7787):471-476. PubMed ID: 31827283
[TBL] [Abstract] [Full Text] [Related]
14. Cimp-Positive Status is More Representative in Multiple Colorectal Cancers than in Unique Primary Colorectal Cancers.
Tapial S; Olmedillas-López S; Rueda D; Arriba M; García JL; Vivas A; Pérez J; Pena-Couso L; Olivera R; Rodríguez Y; García-Arranz M; García-Olmo D; González-Sarmiento R; Urioste M; Goel A; Perea J
Sci Rep; 2019 Jul; 9(1):10516. PubMed ID: 31324877
[TBL] [Abstract] [Full Text] [Related]
15. Radiotherapy resistance acquisition in Glioblastoma. Role of socs1 and SOCS3.
Ventero MP; Fuentes-Baile M; Quereda C; Perez-Valeciano E; Alenda C; Garcia-Morales P; Esposito D; Dorado P; Manuel Barbera V; Saceda M
PLoS One; 2019; 14(2):e0212581. PubMed ID: 30811476
[TBL] [Abstract] [Full Text] [Related]
16. Effect of socs1 silencing on proliferation and apoptosis of melanoma cells: An in vivo and in vitro study.
Yu SJ; Long ZW
Tumour Biol; 2017 May; 39(5):1010428317694315. PubMed ID: 28466787
[TBL] [Abstract] [Full Text] [Related]
17. Correlative analyses of the expression levels of PIAS3, p-SHP2, socs1 and SOCS3 with STAT3 activation in human astrocytomas.
Liu LH; Li H; Cheng XX; Kong QY; Chen XY; Wu ML; Li Y; Liu J; Li C
Mol Med Rep; 2017 Feb; 15(2):847-852. PubMed ID: 28035384
[TBL] [Abstract] [Full Text] [Related]
18. Suppressor of cytokine signalling-1 induces significant preclinical antitumor effect in malignant melanoma cells.
Tagami-Nagata N; Serada S; Fujimoto M; Tanemura A; Nakatsuka R; Ohkawara T; Murota H; Kishimoto T; Katayama I; Naka T
Exp Dermatol; 2015 Nov; 24(11):864-71. PubMed ID: 26173926
[TBL] [Abstract] [Full Text] [Related]
19. miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokines.
Ji Y; Wrzesinski C; Yu Z; Hu J; Gautam S; Hawk NV; Telford WG; Palmer DC; Franco Z; Sukumar M; Roychoudhuri R; Clever D; Klebanoff CA; Surh CD; Waldmann TA; Restifo NP; Gattinoni L
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):476-81. PubMed ID: 25548153
[TBL] [Abstract] [Full Text] [Related]
20. Effects of suppressor of cytokine signaling 1 silencing on human melanoma cell proliferation and interferon-γ sensitivity.
Xu Y; Wang W; Gou A; Li H; Tian Y; Yao M; Yang R
Mol Med Rep; 2015 Jan; 11(1):583-8. PubMed ID: 25322862
[TBL] [Abstract] [Full Text] [Related]
[Next]
